This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutophagy in Disease and Therapy · Cancer-related molecular mechanisms research · Ferroptosis and cancer prognosis
The journal retracts the 29th October 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors requested retraction due to the image integrity concerns, which was then investigated and conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors agreed with the retraction.
